glp 1 drugs depression Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? People with pre-existing depression or

Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma

Circulation 5-1-1996;93(9):1685-1689

Discover how it works, what current research says, its potential benefits, safety, and why its gaining attention in longevity medicine

Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

This marks another milestone in Eli Lillys leadership in metabolic and endocrine innovation